투자판단관련주요경영사항(임상시험계획자진취하등) (NTI7(NIT119, 비소세포폐암) 임상 2상 시험 자진취하)[코]
Received: 4/24/2026 · Reporter: 네오이뮨텍
네오이뮨텍은 2026년 4월 24일 NTI7(NIT119, 비소세포폐암) 임상 2상 시험을 자진 취하하였다고 공시하였다.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 37 filings
- Same category
- 25 filings
- Previous same-category filing
- 8/19/2026
- Corrections / withdrawals
- 4 filings
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).